APA (7th ed.) Citation

Bird, T., Shiarli, A., Burcombe, R., Taylor, H., Cominos, M., Beesley, S., . . . Sevitt, T. (2014). 183 Treating extensive stage small cell lung carcinoma in poor performance status patients – is a high 30 day mortality rate justifiable? Lung Cancer (01695002), 83(s1), S68. https://doi.org/10.1016/S0169-5002(14)70184-9

Chicago Style (17th ed.) Citation

Bird, T., A. Shiarli, R. Burcombe, H. Taylor, M. Cominos, S. Beesley, A. Visioli, R. Shah, and T. Sevitt. "183 Treating Extensive Stage Small Cell Lung Carcinoma in Poor Performance Status Patients – Is a High 30 Day Mortality Rate Justifiable?" Lung Cancer (01695002) 83, no. s1 (2014): S68. https://doi.org/10.1016/S0169-5002(14)70184-9.

MLA (9th ed.) Citation

Bird, T., et al. "183 Treating Extensive Stage Small Cell Lung Carcinoma in Poor Performance Status Patients – Is a High 30 Day Mortality Rate Justifiable?" Lung Cancer (01695002), vol. 83, no. s1, 2014, p. S68, https://doi.org/10.1016/S0169-5002(14)70184-9.